CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

(2008) Fabrizio Montecucco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation

(2008) Jian Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cannabis arteritis

(2008) Bernard Noël et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

CB2cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration

(2007) M Rajesh et al.   BRITISH JOURNAL OF PHARMACOLOGY